138 related articles for article (PubMed ID: 19227478)
21. Assessment of microvascular density, extracellular volume fraction, and radiobiological hypoxia in human melanoma xenografts by dynamic contrast-enhanced MRI.
Vestvik IK; Egeland TA; Gaustad JV; Mathiesen B; Rofstad EK
J Magn Reson Imaging; 2007 Oct; 26(4):1033-42. PubMed ID: 17896373
[TBL] [Abstract][Full Text] [Related]
22. Vascular density in melanoma xenografts correlates with vascular permeability factor expression but not with metastatic potential.
Westphal JR; van't Hullenaar RG; van der Laak JA; Cornelissen IM; Schalkwijk LJ; van Muijen GN; Wesseling P; de Wilde PC; Ruiter DJ; de Waal RM
Br J Cancer; 1997; 76(5):561-70. PubMed ID: 9303353
[TBL] [Abstract][Full Text] [Related]
23. Assessment of extravascular extracellular space fraction in human melanoma xenografts by DCE-MRI and kinetic modeling.
Benjaminsen IC; Brurberg KG; Ruud EB; Rofstad EK
Magn Reson Imaging; 2008 Feb; 26(2):160-70. PubMed ID: 17692490
[TBL] [Abstract][Full Text] [Related]
24. S100A4 expression with reduced E-cadherin expression predicts distant metastasis of human malignant melanoma cell lines in the NOD/SCID/gammaCnull (NOG) mouse model.
Ikoma N; Yamazaki H; Abe Y; Oida Y; Ohnishi Y; Suemizu H; Matsumoto H; Matsuyama T; Ohta Y; Ozawa A; Ueyama Y; Nakamura M
Oncol Rep; 2005 Sep; 14(3):633-7. PubMed ID: 16077966
[TBL] [Abstract][Full Text] [Related]
25. Quantitative assessment of hypoxia in melanoma xenografts by dynamic contrast-enhanced magnetic resonance imaging: intradermal versus intramuscular tumors.
Gulliksrud K; Mathiesen B; Galappathi K; Rofstad EK
Radiother Oncol; 2010 Nov; 97(2):233-8. PubMed ID: 20934767
[TBL] [Abstract][Full Text] [Related]
26. Two human melanoma xenografts with different metastatic capacity and glycosaminoglycan pattern.
Timár J; Kovalszky I; Paku S; Lapis K; Kopper L
J Cancer Res Clin Oncol; 1989; 115(6):554-7. PubMed ID: 2606930
[TBL] [Abstract][Full Text] [Related]
27. Dynamic Contrast-Enhanced Magnetic Resonance Imaging of Ocular Melanoma as a Tool to Predict Metastatic Potential.
Wei W; Jia G; von Tengg-Kobligk H; Heverhagen JT; Abdel-Rahman M; Wei L; Christoforidis JB; Davidorf F; Knopp MV
J Comput Assist Tomogr; 2017; 41(5):823-827. PubMed ID: 28448404
[TBL] [Abstract][Full Text] [Related]
28. Quantitative assessment of uptake and distribution of iron oxide particles (NC100150) in human melanoma xenografts by contrast-enhanced MRI.
Graff BA; Vangberg L; Rofstad EK
Magn Reson Med; 2004 Apr; 51(4):727-35. PubMed ID: 15065245
[TBL] [Abstract][Full Text] [Related]
29. Optical Redox Imaging of Lonidamine Treatment Response of Melanoma Cells and Xenografts.
Xu HN; Feng M; Nath K; Nelson D; Roman J; Zhao H; Lin Z; Glickson J; Li LZ
Mol Imaging Biol; 2019 Jun; 21(3):426-435. PubMed ID: 30151646
[TBL] [Abstract][Full Text] [Related]
30. Assessment of tumor blood perfusion by high-resolution dynamic contrast-enhanced MRI: a preclinical study of human melanoma xenografts.
Benjaminsen IC; Graff BA; Brurberg KG; Rofstad EK
Magn Reson Med; 2004 Aug; 52(2):269-76. PubMed ID: 15282808
[TBL] [Abstract][Full Text] [Related]
31. Intratumor heterogeneity in blood perfusion in orthotopic human melanoma xenografts assessed by dynamic contrast-enhanced magnetic resonance imaging.
Gaustad JV; Benjaminsen IC; Graff BA; Brurberg KG; Ruud EB; Rofstad EK
J Magn Reson Imaging; 2005 Jun; 21(6):792-800. PubMed ID: 15906326
[TBL] [Abstract][Full Text] [Related]
32. Dynamic contrast-enhanced magnetic resonance imaging of tumors: preclinical validation of parametric images.
Egeland TA; Simonsen TG; Gaustad JV; Gulliksrud K; Ellingsen C; Rofstad EK
Radiat Res; 2009 Sep; 172(3):339-47. PubMed ID: 19708783
[TBL] [Abstract][Full Text] [Related]
33. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
Huang S; Xie K; Bucana CD; Ullrich SE; Bar-Eli M
Clin Cancer Res; 1996 Dec; 2(12):1969-79. PubMed ID: 9816156
[TBL] [Abstract][Full Text] [Related]
34. Orthotopic human choroidal melanoma xenografts in nude rats with aggressive and nonaggressive PAS staining patterns.
Braun RD; Abbas A
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):7-16. PubMed ID: 16384938
[TBL] [Abstract][Full Text] [Related]
35. Metastatic potential of four human melanoma xenografts in young athymic mice following tail vein inoculation.
Zimmerman RJ; Gaillard ET; Goldin A
Cancer Res; 1987 May; 47(9):2305-10. PubMed ID: 3567924
[TBL] [Abstract][Full Text] [Related]
36. Limitations of dynamic contrast-enhanced MRI in monitoring radiation-induced changes in the fraction of radiobiologically hypoxic cells in human melanoma xenografts.
Benjaminsen IC; Melås EA; Mathiesen BS; Rofstad EK
J Magn Reson Imaging; 2008 Nov; 28(5):1209-18. PubMed ID: 18972344
[TBL] [Abstract][Full Text] [Related]
37. Vascular abnormalities and development of hypoxia in microscopic melanoma xenografts.
Gaustad JV; Simonsen TG; Andersen LMK; Rofstad EK
J Transl Med; 2017 Nov; 15(1):241. PubMed ID: 29183378
[TBL] [Abstract][Full Text] [Related]
38. In vitro properties of human melanoma cells metastatic in nude mice.
Herlyn D; Iliopoulos D; Jensen PJ; Parmiter A; Baird J; Hotta H; Adachi K; Ross AH; Jambrosic J; Koprowski H
Cancer Res; 1990 Apr; 50(8):2296-302. PubMed ID: 2156614
[TBL] [Abstract][Full Text] [Related]
39. REDOX IMAGING OF THE p53-DEPENDENT MITOCHONDRIAL REDOX STATE IN COLON CANCER
Xu HN; Feng M; Moon L; Dolloff N; El-Deiry W; Li LZ
J Innov Opt Health Sci; 2013 Jul; 6(3):. PubMed ID: 26207147
[TBL] [Abstract][Full Text] [Related]
40. Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging.
Lyng H; Haraldseth O; Rofstad EK
Magn Reson Med; 2000 Jun; 43(6):828-36. PubMed ID: 10861877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
